Processing and presentation of a mycobacterial antigen 85B epitope by murine macrophages is dependent on the phagosomal acquisition of vacuolar proton ATPase and in situ activation of cathepsin D.
Mycobacterium tuberculosis (strain H37Rv) and bacillus Calmette-Guérin (BCG) vaccine inhibit phagosome maturation in macrophages and their effect on processing, and presentation of a secreted Ag85 complex B protein, Ag85B, by mouse macrophages was analyzed. Macrophages were infected with GFP-expressing mycobacterial strains and analyzed for in situ localization of vacuolar proton ATPase (v-ATPase) and cathepsin D (Cat D) using Western blot analysis and immunofluorescence. H37Rv and BCG phagosomes excluded the v-ATPase and maintained neutral pH while the attenuated H37Ra strain acquired v-ATPase and acidified. Mycobacterial phagosomes acquired Cat D, although strains BCG and H37Rv phagosomes contained the inactive 46-kDa form, whereas H37Ra phagosomes had the active 30-kDa form. Infected macrophages were overlaid with a T cell hybridoma specific for an Ag85B epitope complexed with MHC class II. Coincident with active Cat D, H37Ra-infected macrophages presented the epitope to T cells inducing IL-2, whereas H37Rv- and BCG-infected macrophages were less efficient in IL-2 induction. Bafilomycin inhibited the induction of macrophage-induced IL-2 from T cells indicating that v-ATPase was essential for macrophage processing of Ag85B. Furthermore, the small interfering RNA interference of Cat D synthesis resulted in a marked decrease in the levels of macrophage-induced IL-2. Thus, a v-ATPase-dependent phagosomal activation of Cat D was required for the generation of an Ag85B epitope by macrophages. Reduced processing of Ag85B by H37Rv- and BCG-infected macrophages suggests that phagosome maturation arrest interferes with the efficient processing of Ags in macrophages. Because Ag85B is immunodominant, this state may lead to a decreased ability of the wild-type as well as the BCG vaccine to induce protective immunity.
Singh
Christopher R
CR
Department of Pathology and Laboratory Medicine, University of Texas Health Science Center, Houston 77030, USA.
Moulton
Rachel A
RA
Armitige
Lisa Y
LY
Bidani
Akhil
A
Snuggs
Mark
M
Dhandayuthapani
Subramanian
S
Hunter
Robert L
RL
Jagannath
Chinnaswamy
C
D000143:Acids; D000217:Acyltransferases / Q000276:immunology*; D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology*; D002402:Cathepsin D / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D000939:Epitopes / Q000276:immunology*; D006863:Hydrogen-Ion Concentration; D007371:Interferon-gamma / Q000096:biosynthesis; D008264:Macrophages / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009169:Mycobacterium tuberculosis / Q000166:cytology / Q000276:immunology; D010588:Phagosomes / Q000201:enzymology* / Q000276:immunology*; D034741:RNA, Small Interfering / Q000235:genetics; D025262:Vacuolar Proton-Translocating ATPases / Q000378:metabolism*
D000143:Acids; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D000939:Epitopes; D034741:RNA, Small Interfering; D007371:Interferon-gamma; D000217:Acyltransferases; C121433:antigen 85B, Mycobacterium tuberculosis; D002402:Cathepsin D; D025262:Vacuolar Proton-Translocating ATPases